GlassScriptPhysician profile
Jacquelyn A Robinson
NPI 1144490590
$1,262.65
in general payments reported to CMS, 2019-2025
28 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $60.75 · 2021: $210 · 2022: $284 · 2023: $191 · 2024: $194 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $415.80 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $147.94 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Astellas Pharma US INC | $131.42 | 2022-2025 | Veozah |
| Aspira Women'S Health INC | $90.18 | 2021-2022 | |
| Biogen, INC. | $72.44 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $62.98 | 2023-2024 | Myfembree |
| Becton, Dickinson and Company | $48.29 | 2022 | |
| Organon LLC | $42.77 | 2022-2024 | Nexplanon |
| Agile Therapeutics, INC. | $42.69 | 2021-2022 | |
| Boston Scientific Corporation | $40.31 | 2019-2023 | Angiojet Ultra 5000a |
| Coopersurgical, INC. | $29.12 | 2019-2022 | |
| Daiichi Sankyo INC. | $26.92 | 2023 | Injectafer |
| Channel Medsystems, INC. | $25.70 | 2021-2022 | |
| Medtronic, INC. | $23.02 | 2023 | Truclear |
| Merck Sharp & Dohme LLC | $18.83 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $16.02 | 2025 | Enplace |
| Sage Therapeutics, LLC | $15.51 | 2020 | |
| Lupin INC. | $12.71 | 2020 |
10 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.